10-Q: Healthy Extracts Inc. Reports Q1 2024 Results with Revenue Increase but Net Loss

Healthy Extracts Inc. saw a 12% increase in revenue in Q1 2024 compared to Q1 2023, but still reported a net loss.

Summary

• Healthy Extracts Inc. reported a revenue of $688,786 for the quarter ended March 31, 2024, an increase of 12% compared to $614,943 in the same period of 2023.
• The company's cost of revenue decreased by 17% to $280,428 in Q1 2024 from $337,102 in Q1 2023.
• General and administrative expenses decreased by 31% to $470,431 in Q1 2024 from $683,029 in Q1 2023.
• The net loss for the quarter was $861,259, or $0.30 per share, compared to a net loss of $579,157, or $0.20 per share, in Q1 2023.
• The company's cash balance increased to $87,312 as of March 31, 2024, from $19,441 at the end of 2023.
• The company has a going concern issue due to accumulated losses of $19,260,931 and needs to raise capital to continue operations.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with some positive revenue growth but significant concerns about profitability, cash flow, and the company's ability to continue as a going concern. The going concern issue and reliance on external funding are major negatives.

Positives

• The company experienced a 12% increase in revenue, primarily due to increased focus on the Amazon marketplace.
• The cost of revenue decreased by 17%, indicating improved efficiency in production or sourcing.
• General and administrative expenses decreased by 31%, suggesting better cost management.
• The company's cash balance increased significantly from $19,441 to $87,312 during the quarter.

Negatives

• The company reported a net loss of $861,259 for the quarter, which is an increase in losses compared to the same period last year.
• The company has a significant accumulated deficit of $19,260,931.
• The company's auditors have raised concerns about its ability to continue as a going concern.
• The company is reliant on raising capital through debt or equity financing to sustain operations.

Risks

• The company has a going concern issue due to its accumulated losses and negative cash flow.
• The company is dependent on raising capital through debt or equity financing, which may not be successful.
• The company's disclosure controls and procedures were not effective at the reasonable assurance level due to material weaknesses.
• The company's products have not been evaluated by the FDA or any similar regulatory body for safety and efficacy.

Future Outlook

The company anticipates that its cash needs will be satisfied through increased revenues and the issuance of debt or the sale of its securities until such time as its cash flows from operations will satisfy its cash flow needs.

Management Comments

• Management plans to keep seeking funding through debt and equity financing which are intended to mitigate the conditions that have raise substantial doubt about the entitys ability to continue as a going concern.
• The increase in revenues was mainly due to our increased focus on the Amazon marketplace.

Industry Context

The company operates in the nutraceuticals market, which is a high-growth sector. The company's focus on heart, brain, and immune health aligns with current consumer trends. However, the company faces competition and regulatory challenges common in this industry.

Comparison to Industry Standards

• The company's revenue growth of 12% is a positive sign, but it is important to compare this to the average growth rate of other nutraceutical companies of a similar size.
• The decrease in cost of revenue and operating expenses suggests improved efficiency, but further analysis is needed to determine if these are sustainable.
• The net loss and going concern issues are significant concerns and need to be addressed to ensure the company's long-term viability.
• Companies like Herbalife and Nature's Bounty are established players in the nutraceutical market, and Healthy Extracts needs to demonstrate a clear competitive advantage to succeed.

Related Party Transactions

• The company had expenses totaling $0 to an officer and director for salaries for the months ended March 31, 2024 and the year ended December 31, 2023.
• The company has related party notes payable outstanding.

Stakeholder Impact

• Shareholders are at risk due to the company's going concern issue and reliance on external funding.
• Employees may be impacted by the company's financial instability.
• Customers may be affected if the company is unable to continue operations.
• Creditors are at risk due to the company's high debt levels.

Next Steps

• The company needs to continue to focus on increasing revenue and improving profitability.
• The company needs to secure additional funding through debt or equity financing.
• The company needs to address the material weaknesses in its disclosure controls and procedures.
• The company needs to address the going concern issue raised by its auditors.

Key Dates

Keywords

nutraceuticals, revenue, net loss, financial results, going concern, debt financing, equity financing, operating expenses, cash flow, derivative liability